The Wall Street Journal on Mythryl: “Eli Lilly reported higher net income and revenue in the recent…”

Eli Lilly reported higher net income and revenue in the recent quarter, fueled by continued surging demand for its GLP-1 weight-loss drugs. on.wsj.com/4clxdRn

on.wsj.comEli Lilly Posts Higher Revenue on Continued GLP-1 DemandEli Lilly reported higher net income and revenue in the recent quarter, fueled by continued surging demand for its GLP-1 weight-loss drugs.

5/8/26, 11:20 am5 reposts8 likes